Previous 10 | Next 10 |
With greater clarity on the sustainability of the economic recovery, we also saw the opportunity set across markets broaden to include sectors beyond those seen as the primary beneficiaries of an economic reopening. As expected, the recovery hasn't been smooth sailing for all, with su...
MariMed is a vertically integrated multi state cannabis operator. CEO Bob Fireman joins us to discuss why he thinks they're undervalued. Giving guidance, changing messaging and cleaning up balance sheet from previous debt. Full legalization and uplisting closer but still far off -...
Canopy Growth recently announced it was acquiring Supreme Cannabis, a promising turnaround story out of Canada. Supreme CEO Beena Goldenberg discusses why CGC was the most compelling suitor, strengthening Canadian position before turning to the US, Acreage and TerrAscend relationships...
Vireo Health Founder and CEO Dr. Kyle Kingsley returns to the show to talk huge opportunity in US as Arizona, New Mexico, and New York legalize adult use cannabis. Legalization doesn't automatically improve your business unless you can scale on operational excellence. Compelling p...
Greenlane and KushCo announced their merger last month; today, GNLN CEO Aaron LoCascio joins us to discuss being the consolidator of choice. Capitalizing on cannabis CPG space, the advantages of being on Nasdaq, moving beyond tobacco and the vaping crisis. What the combined entity...
Vireo Health Founder and CEO Dr. Kyle Kingsley returns to the show to talk huge opportunity in US as Arizona, New Mexico, and New York legalize adult use cannabis. Legalization doesn't automatically improve your business unless you can scale on operational excellence. Compelling p...
Happy 4/20! To celebrate, we're joined by Kaelan Castetter and Allan Gandelman, who played an integral part in New York legalizing cannabis. The key to true social equity and why limited licenses stifle innovation and create an unequitable marketplace. Very bullish on non-psychoac...
CHICAGO, April 20, 2021 (GLOBE NEWSWIRE) -- Amplify ETFs is pleased to announce the Amplify Seymour Cannabis ETF (NYSE: CNBS) now has the ability to access Multi-State Operators (MSOs) via swaps. The ETF recently completed both legal and operational work in order to add portfolio ex...
Access to the U.S. banking system will be less burdensome now for companies dealing into marijuana after the House passed cannabis banking bill on Monday evening, source MarketWatch.Lawmakers voted 321-101 to approve the bill and send it to the Senate.A bill sponsored by Rep. Ed Perlmutter, a...
Cannabis industry as it stands today is 5% of what it's going to be - so says Jay Czarkowski, Founding Partner at Canna Advisors. Chasing competitive licenses, opportunities in MORE Act, MSOs primed to succeed, as well as some under the radar companies. Companies likely to be acqu...
News, Short Squeeze, Breakout and More Instantly...
Amplify ETF Trust - Amplify Seymour Cannabis ETF Company Name:
CNBS Stock Symbol:
NYSE Market:
2024-01-19 07:30:51 ET The Leading Cannabis ETFs to Consider in 2024 Cannabis ETFs are garnering attention in 2024 as the industry shows promising growth. Key players like MJ, MSOS, and CNBS dominate this sector. These ETFs offer diversified exposure to cannabis-related stocks. This...
2023-10-27 07:30:02 ET Q4 2023’s Cannabis ETF Leaders: Where to Invest The cannabis sector continues to entice investors with its prospects for expansion and financial success as we take on the last quarter of 2023. Cannabis Exchange-Traded Funds (ETFs) have become popular for in...
2023-09-15 07:30:42 ET Top Marijuana ETFs for September 2023 In 2023, the cannabis industry and top marijuana stocks are blazing a trail of exponential growth, presenting investors with a unique opportunity to tap into this flourishing sector. As regulatory landscapes evolve and soc...